Skip to main content
Clinical Trials/PACTR202211501864857
PACTR202211501864857
Not yet recruiting
Phase 1

The Value of Local Dexmedetomidine as an Adjuvant to WALANT Anesthesia in Flexor Tendon Repair Surgeries

May E Badr0 sites128 target enrollmentNovember 10, 2022
ConditionsAnaesthesia

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Anaesthesia
Sponsor
May E Badr
Enrollment
128
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 10, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
May E Badr

Eligibility Criteria

Inclusion Criteria

  • adult patients diagnosed with a flexor tendon injury in the hand region, scheduled for surgical intervention under WALANT, and classified as class I or II according to the American Society of Anesthesiologists (ASA)

Exclusion Criteria

  • Patients have bleeding diathesis,
  • ASA class III or more,
  • patients have known allergies to any of the study medications.
  • patients with concomitant bony fractures or requiring digital nerve repair.

Outcomes

Primary Outcomes

Not specified

Similar Trials